Actively Recruiting
Improving Quality of Life in Older Patients With Frailty and Hematological Cancer Through Geriatric Assessment
Led by Odense University Hospital · Updated on 2024-04-18
152
Participants Needed
1
Research Sites
130 weeks
Total Duration
On this page
Sponsors
O
Odense University Hospital
Lead Sponsor
V
Velux Fonden
Collaborating Sponsor
AI-Summary
What this Trial Is About
The Improve study is a randomized controlled trial investigating the efficacy of adding comprehensive geriatric assessment and treatment to standard of care compared with standard of care in older, frail patients with hematological cancer. The investigators aim to recruit 152 study participants who will be randomized 1:1 to intervention- or control group. Study participants in the intervention group will receive the intervention comprehensive geriatric assessment and treatment integrated in the cancer treatment. Study participants in the control group will receive cancer treatment and evaluation of comorbidity and frailty as is usual standard at Department of Hematology. Primary endpoint is elderly functional Index at 12 weeks.
CONDITIONS
Official Title
Improving Quality of Life in Older Patients With Frailty and Hematological Cancer Through Geriatric Assessment
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 70 years or older
- New diagnosis or progression/relapse of acute leukemia, chronic myeloid leukemia, chronic lymphocytic leukemia, myelodysplastic syndrome, lymphoma, multiple myeloma, chronic myelomonocytic leukemia or myelofibrosis
- Scheduled to start systemic cancer treatment or started treatment within 6 weeks
- Geriatric 8 frailty score of 14 or less at screening
- Life expectancy longer than 6 months
- Not hospitalized at the time of inclusion
You will not qualify if you...
- Receiving systemic treatment for another cancer, except for anti-hormone treatment for breast or prostate cancer without recent disease progression
- Seen a geriatric outpatient clinic within the past 6 months
- Requires specialized neuro-rehabilitation
- Unable to understand Danish
- Unable to give written informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Odense University Hospital
Odense C, Denmark, 5000
Actively Recruiting
Research Team
H
Henrik Frederiksen
CONTACT
N
Nina Andersen
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here